[Effects of lianhuang decoction in treating fetomaternal ABO blood group incompatibility].
OBJECTIVE
To investigate the clinical curative effect of Lianhuang Decoction (LHD) in treating fetomaternal ABO blood group incompatibility (FM-ABOI).


METHODS
Sixty pregnancy women diagnosed as FM-ABOI were randomly assigned to two groups, Group A treated with LHD and Group B treated with Western medicine. The therapeutic efficacy in the two groups was observed.


RESULTS
The antibody titer decreased after treatment in both groups to different extent; the effective rate was 90.0% in Group A and 56.7% in Group B. The bilirubin level in cord blood of Group A was lower than that in Group B significantly (P<0.01). No statistically significant difference was found between the two groups new-bom in terms of 5-minute Apgar score, body weight and hemoglobin content in cord blood (P>0.05).


CONCLUSIONS
LHD has good clinical curative effect in treating FM-ABOI, could decrease the serum antibody titer, and prevent the occurrence of postpartum hemolytic disease in newborns.
Cai
Zhu-Hua
ZH
The Third Affiliated Hospital of Wenzhou Medical College, Zhejiang. caizhuhua12@163.com
Chen
Ying-Yi
YY
Zeng
Jue
J
D000017:ABO Blood-Group System; D000328:Adult; D001787:Blood Group Incompatibility / Q000188:drug therapy*; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000517:prevention & control; D008517:Phytotherapy; D011247:Pregnancy; D055815:Young Adult
D000017:ABO Blood-Group System; D004365:Drugs, Chinese Herbal